戻る Agenda
[V8-S3] Call for Abstract Session
Session Chair(s)
Kazuhiro Kanmuri, PHD
Executive Officer, Head of Development Div., Tanabe Pharma Corporation, Japan
Koichiro Yuji, MD, PHD, FACP
Project Associate Professor, The Institute of Medical Science, Japan
Four outstanding research speakers are selected for this year’s Call for Abstract session out of more than large number of applications from Japan and overseas compared to the last year from various themes through a rigorous selection process. Speakers show their knowledge, experience, and research suited to the theme of this annual meeting. Current hot topics will be beneficial to your future business in medicine development.
Speaker(s)
Glenn Carroll, MBA
Principal, Deloitte, United States
Transforming Pharmacovigilance through Robotic Process Automation and Cognitive Technologies
Dinah Duarte, MSC
Signal Management Lead, European Medicines Agency, Netherlands
Rare Diseases in the Era of Precision Medicine
Kenny Peng, MSC, RAC
Managing Director, Asia, Pharmeng Technology Pte. Ltd., Singapore
ASEAN Therapeutic Product Market Access & Regulatory Strategy
Jorg Taubel, MD, FFPM
Chief Executive Officer, Richmond Pharmacology, United Kingdom
Integration of ICH E14 Cardiac safety in Phase I studies and Validation of exposure-QTc relationships